Vylor (NYSE:VYLR) Upgraded to Sell at Wall Street Zen

Wall Street Zen upgraded shares of Vylor (NYSE:VYLR) to a sell rating in a research report report published on Saturday morning,Wall Street Zen reports.

A number of other equities analysts have also recently weighed in on the company. Weiss Ratings initiated coverage on Vylor in a report on Friday, October 2nd. They issued a “sell (d+)” rating for the company. KeyCorp began coverage on shares of Vylor in a research note on Wednesday. They set a “sector weight” rating and a $78.00 price objective on the stock. BMO Capital Markets initiated coverage on shares of Vylor in a research report on Friday, October 2nd. They set an “outperform” rating and a $85.00 target price on the stock. Bank of America started coverage on shares of Vylor in a research note on Monday, October 5th. They issued a “buy” rating and a $78.00 target price for the company. Finally, Morgan Stanley assumed coverage on shares of Vylor in a report on Friday, October 2nd. They set an “overweight” rating and a $85.00 price target for the company. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Vylor presently has an average rating of “Moderate Buy” and an average target price of $82.00.

Vylor Price Performance

VYLR stock opened at $72.82 on Friday. Vylor has a 1 year low of $65.00 and a 1 year high of $75.49.

Vylor Company Profile

Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.